TrialNeurology(R) neuroimmunology & neuroinflammation2019

Long-term safety and efficacy of subcutaneous immunoglobulin IgPro20 in CIDP: PATH extension study.

Ivo N van Schaik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.